199 related articles for article (PubMed ID: 36820078)
1. Epigenetic drug library screening reveals targeting DOT1L abrogates NAD
Gu X; Hua Y; Yu J; Yang L; Ge S; Jia R; Chai P; Zhuang A; Fan X
J Pharm Anal; 2023 Jan; 13(1):24-38. PubMed ID: 36820078
[TBL] [Abstract][Full Text] [Related]
2. Silencing or inhibition of H3K79 methyltransferase DOT1L induces cell cycle arrest by epigenetically modulating c-Myc expression in colorectal cancer.
Yang L; Lei Q; Li L; Yang J; Dong Z; Cui H
Clin Epigenetics; 2019 Dec; 11(1):199. PubMed ID: 31888761
[TBL] [Abstract][Full Text] [Related]
3. Methyltransferase Dot1l preferentially promotes innate IL-6 and IFN-β production by mediating H3K79me2/3 methylation in macrophages.
Chen X; Liu X; Zhang Y; Huai W; Zhou Q; Xu S; Chen X; Li N; Cao X
Cell Mol Immunol; 2020 Jan; 17(1):76-84. PubMed ID: 30275539
[TBL] [Abstract][Full Text] [Related]
4. Prognostic and therapeutic value of disruptor of telomeric silencing-1-like (DOT1L) expression in patients with ovarian cancer.
Zhang X; Liu D; Li M; Cao C; Wan D; Xi B; Li W; Tan J; Wang J; Wu Z; Ma D; Gao Q
J Hematol Oncol; 2017 Jan; 10(1):29. PubMed ID: 28114995
[TBL] [Abstract][Full Text] [Related]
5. AF10 (MLLT10) prevents somatic cell reprogramming through regulation of DOT1L-mediated H3K79 methylation.
Uğurlu-Çimen D; Odluyurt D; Sevinç K; Özkan-Küçük NE; Özçimen B; Demirtaş D; Enüstün E; Aztekin C; Philpott M; Oppermann U; Özlü N; Önder TT
Epigenetics Chromatin; 2021 Jul; 14(1):32. PubMed ID: 34215314
[TBL] [Abstract][Full Text] [Related]
6. Targeting Histone Methyltransferase DOT1L by a Novel Psammaplin A Analog Inhibits Growth and Metastasis of Triple-Negative Breast Cancer.
Byun WS; Kim WK; Han HJ; Chung HJ; Jang K; Kim HS; Kim S; Kim D; Bae ES; Park S; Lee J; Park HG; Lee SK
Mol Ther Oncolytics; 2019 Dec; 15():140-152. PubMed ID: 31720371
[TBL] [Abstract][Full Text] [Related]
7. The histone methyltransferase DOT1L: regulatory functions and a cancer therapy target.
Wong M; Polly P; Liu T
Am J Cancer Res; 2015; 5(9):2823-37. PubMed ID: 26609488
[TBL] [Abstract][Full Text] [Related]
8. Differential Methylation of H3K79 Reveals DOT1L Target Genes and Function in the Cerebellum In Vivo.
Bovio PP; Franz H; Heidrich S; Rauleac T; Kilpert F; Manke T; Vogel T
Mol Neurobiol; 2019 Jun; 56(6):4273-4287. PubMed ID: 30302725
[TBL] [Abstract][Full Text] [Related]
9. DOT1L/KMT4 recruitment and H3K79 methylation are ubiquitously coupled with gene transcription in mammalian cells.
Steger DJ; Lefterova MI; Ying L; Stonestrom AJ; Schupp M; Zhuo D; Vakoc AL; Kim JE; Chen J; Lazar MA; Blobel GA; Vakoc CR
Mol Cell Biol; 2008 Apr; 28(8):2825-39. PubMed ID: 18285465
[TBL] [Abstract][Full Text] [Related]
10. DOT1L-mediated H3K79 methylation in chromatin is dispensable for Wnt pathway-specific and other intestinal epithelial functions.
Ho LL; Sinha A; Verzi M; Bernt KM; Armstrong SA; Shivdasani RA
Mol Cell Biol; 2013 May; 33(9):1735-45. PubMed ID: 23428873
[TBL] [Abstract][Full Text] [Related]
11. Folate deficiency reduced aberrant level of DOT1L-mediated histone H3K79 methylation causes disruptive SHH gene expression involved in neural tube defects.
Li X; Pei P; Shen J; Yu J; Wang F; Wang L; Liu C; Wang S
Epigenetics Chromatin; 2023 Dec; 16(1):50. PubMed ID: 38093377
[TBL] [Abstract][Full Text] [Related]
12. DOT1L Regulates Thermogenic Adipocyte Differentiation and Function via Modulating H3K79 Methylation.
Shuai L; Li BH; Jiang HW; Yang L; Li J; Li JY
Diabetes; 2021 Jun; 70(6):1317-1333. PubMed ID: 33795413
[TBL] [Abstract][Full Text] [Related]
13. DOT1L inhibition enhances pluripotency beyond acquisition of epithelial identity and without immediate suppression of the somatic transcriptome.
Wille CK; Sridharan R
Stem Cell Reports; 2022 Feb; 17(2):384-396. PubMed ID: 34995500
[TBL] [Abstract][Full Text] [Related]
14. Regulation of Wnt signaling target gene expression by the histone methyltransferase DOT1L.
Gibbons GS; Owens SR; Fearon ER; Nikolovska-Coleska Z
ACS Chem Biol; 2015 Jan; 10(1):109-14. PubMed ID: 25361163
[TBL] [Abstract][Full Text] [Related]
15. Dot1L mediated histone H3 lysine79 methylation is essential to meiosis progression in mouse oocytes.
Wang X; Gao W; Ma X; Wang X; Song C; Huang X; Liu H
Neuro Endocrinol Lett; 2014; 35(6):523-30. PubMed ID: 25433842
[TBL] [Abstract][Full Text] [Related]
16. The histone methyltransferase Dot1/DOT1L as a critical regulator of the cell cycle.
Kim W; Choi M; Kim JE
Cell Cycle; 2014; 13(5):726-38. PubMed ID: 24526115
[TBL] [Abstract][Full Text] [Related]
17. The histone H3K79 methyltransferase Dot1L is essential for mammalian development and heterochromatin structure.
Jones B; Su H; Bhat A; Lei H; Bajko J; Hevi S; Baltus GA; Kadam S; Zhai H; Valdez R; Gonzalo S; Zhang Y; Li E; Chen T
PLoS Genet; 2008 Sep; 4(9):e1000190. PubMed ID: 18787701
[TBL] [Abstract][Full Text] [Related]
18. Nullifying epigenetic writer DOT1L attenuates neointimal hyperplasia.
Huang Y; Urabe G; Zhang M; Li J; Ozer HG; Wang B; Kent KC; Guo LW
Atherosclerosis; 2020 Sep; 308():22-31. PubMed ID: 32799103
[TBL] [Abstract][Full Text] [Related]
19. The Histone Methyltransferase DOT1L Promotes Neuroblastoma by Regulating Gene Transcription.
Wong M; Tee AEL; Milazzo G; Bell JL; Poulos RC; Atmadibrata B; Sun Y; Jing D; Ho N; Ling D; Liu PY; Zhang XD; Hüttelmaier S; Wong JWH; Wang J; Polly P; Perini G; Scarlett CJ; Liu T
Cancer Res; 2017 May; 77(9):2522-2533. PubMed ID: 28209620
[TBL] [Abstract][Full Text] [Related]
20. Blocking the histone lysine 79 methyltransferase DOT1L alleviates renal fibrosis through inhibition of renal fibroblast activation and epithelial-mesenchymal transition.
Liu L; Zou J; Guan Y; Zhang Y; Zhang W; Zhou X; Xiong C; Tolbert E; Zhao TC; Bayliss G; Zhuang S
FASEB J; 2019 Nov; 33(11):11941-11958. PubMed ID: 31373855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
